AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES

Go back to AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
Amgen Inc (NASDAQ: AMGN) Delayed: 406.09 --0 (-0%)
Previous Close $406.09    52 Week High $176.85 
Open $406.09    52 Week Low $133.64 
Day High $406.09    P/E 61.16 
Day Low $406.09    EPS $6.64 
Volume 2,327